Evaluation of Interactions of Selected Olivacine Derivatives with DNA and Topoisomerase II
Olivacine and ellipticine are model anticancer drugs acting as topoisomerase II inhibitors. Here, we present investigations performed on four olivacine derivatives in light of their antitumor activity. The aim of this study was to identify the best antitumor compound among the four tested olivacine...
Main Authors: | Beata Tylińska, Agnieszka Dobosz, Jan Spychała, Łucja Cwynar-Zając, Żaneta Czyżnikowska, Amadeusz Kuźniarski, Tomasz Gębarowski |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-08-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/16/8492 |
Similar Items
-
Antitumor Activity of New Olivacine Derivatives
by: Janusz Piasny, et al.
Published: (2020-05-01) -
Bioactive Olivacine Derivatives—Potential Application in Cancer Therapy
by: Beata Tylińska, et al.
Published: (2021-06-01) -
Synthesis and Activity against Mycobacterium tuberculosis of Olivacine and Oxygenated Derivatives
by: Ulrike Schmidt, et al.
Published: (2018-06-01) -
Secondary Leukemia Associated with the Anti-Cancer Agent, Etoposide, a Topoisomerase II Inhibitor
by: Sachiko Ezoe
Published: (2012-07-01) -
Structural and Biochemical Basis of Etoposide-Resistant Mutations in Topoisomerase IIα
by: Deweese, J.E, et al.
Published: (2022)